Phenotypic and Functional Deficiency of Natural Killer Cells in Patients with Chronic Fatigue Syndrome. M Caligiuri, D Buchwald, P Cheney, D Peterson, AL Komaroff et al. The Journal of Immunology 1987:139:10:3306-3313


What is myalgic encephalomyelitis? AR Lloyd, D Wakefield, C Boughton, J Dwyer. Lancet 1988:1286-1287

IgG subclass deficiency in chronic fatigue syndrome. AL Komaroff et al Lancet 1988:4th June


Interleukin-2 and the Chronic Fatigue Syndrome. PR Cheney, SE Dorman, DS Bell. Ann Int Med 1989 110-4:321

Immunological abnormalities in the chronic fatigue syndrome. AR Lloyd et al Med J Aust. 1989:151:124

Immune function and the chronic fatigue syndrome. Leading Article. W Gin et al Med J Aust 1989:151:117-118

Natural Killer Cell Activity in the Chronic Fatigue-immune Dysfunction Syndrome NL Eby, S Grufferman, RB Herberman et al. In: Natural Killer Cells and Host Defense. Eds: Ades EW, Lopez C. Karger, Basle, 1989: 141-145. Proceedings of 5h International Natural Killer Cell Workshop. Hilton head, SC 1988.

Human IgE Response: Virus-Activated IgE Secretors are Interleukin-2-Dependent Cells. MA Chan, HM Dosch. Int Arch Allergy Appl Immunol 1989: 89:90-97


Myalgic encephalomyelitis: an alternative theory. CWM Wilson. JRSM 1990: 83:8:481483

Immunologic Abnormalities in Chronic Fatigue Syndrome. Nancy G Klimas et al J Clin Microbiol 1990:28:6:1403-1410

CD8 Deficiency in Patients with Muscle Fatigue Following Suspected Enteroviral Infections (Myalgia Encephalitica). JR Hobbs, J Mowbray, JE Monroe et al In: Profides of the Biological Fluids, Jan 1990, vol 36:391-398


Immunology of Postviral Fatigue Syndrome. JF Mowbray, GE Yousef. British Medical Journal 1991:4 7.4:886-894

Nervous System-immune System Communication. BGW Arnasonj. Reviews of Infectious Diseases 1991:13(Suppl 1):S134-7

Immunologic Abnormalities Accompanying Acute and Chronic Viral Infections. DE Griffin. Reviews of Infectious Diseases 1991:13(Suppl 1):S129-33

Sources of Confounding in Immunologic Data. RB Herberman. Reviews of Infectious Diseases 1991:13(Suppl 1):S84-6

Natural Killer Cells and the Post Viral Fatigue Syndrome. DO Ho-Yen, RW Billington, J Urquhart. Scand J Infect Dis 1991:23:711-716

Changes in natural killer cell phenotype in patients with post-viral fatigue syndrome. LJA Morrison, WHM Behan, PO Behan. Clin. Exp. Immunol 1991:83:441-446

A Comprehensive Immunological Analysis in Chronic Fatigue Syndrome. S Gupta, B Vayuvegula. Scand. J. Immunol 1991:33:319-327

Chronic Fatigue Syndrome - An Overview. P Cheney.

Chronic fatigue syndrome: clinical condition associated with immune activation. AL Landay, C Jessop et al. The Lancet 1991:338:707-12


A Chronic Illness Characterized by Fatigue, Neurologic and Immunologic Disorders, and Active Human Herpesvirus Type 6 Infection. D Buchwald, PR Cheney et al. Annals of Internal Medicine 1992:116:2:103-111


Chronic Fatigue Syndrome: Is It a State of Chronic Immune Activation Against an Infectious Virus? JA Levy, AL Landay et al. Contemp Issues Infec. Dis. 1993:10:127-146

Immunity and the pathophysiology of chronic fatigue syndrome. AR Lloyd, D Wakefield, I Hickie. Chronic fatigue syndrome 1993. Wiley, Chichester (Ciba Foundation Symposium 173):176-192


Immunological Abnormalities in Patients with Chronic Fatigue Syndrome. U Tirelli, G Marotta et al. Scand. J. Immunol 1994:40:601-608

Simultaneous Measurement of Antibodies to Epstein-Barr Virus, Human Herpesvirus 6, Simplex Virus Types 1 and 2, and 14 Enteroviruses in Chronic Fatigue Syndrome: Is There Evidence of Activation of a Nonspecific Polyclonal Immune Response? FA Marrin. Clinical Infectious Diseases 1994:19:448-53

Decreased Natural Killer Cell Activity Is Associated with Severity of Chronic Fatigue Immune Dysfunction Syndrome. EA Ojo-Amaize, EJ Conley, JB Peter. Clinical Infectious Diseases 1994:18(Suppl 1):S157-9

Association Between HLA Class 11 Antigens and the Chronic Fatigue Immune Dysfunction Syndrome. RH Keller, JL Lane et al. Clinical Infectious Diseases 1994:18(Suppl 1):S154-6

Dysregulated Expression of Tumor Necrosis Factor in Chronic Fatigue Syndrome: Interrelations with Cellular Sources and Patterns of Soluble Immune Mediator Expression. R Patarca, NG Klimas et al. Clinical Infectious Diseases 1994:18(Suppl 1):S147-53

Upregulation of the 2-5A Synthetase/RNase L Antiviral Pathway Associated with Chronic Fatigue Syndrome. RJ Suhadolnik, NL Reichenbach et al. Clinical Infectious Diseases 1994:18(Suppl 1):S96-104

Immunologic Abnormalities Associated with Chronic Fatigue Syndrome. Ebarker, SF Fujimara et al. Clinical Infectious Diseases 1994:18(Suppl 1):S136-41

Part IV: Immunologic Studies of Chronic Fatigue Syndrome. AR Lloyd. Clinical Infectious Diseases 1994:18(Suppl 1):S134-5

Summary: Immunologic Studies of Chronic Fatigue Syndrome. AR Lloyd, N Klimas. Clinical Infectious Diseases 1994:18(Suppl 1):S160-1

Summary and Perspective: Epidemiology of Chronic Fatigue Syndrome. PH Levine. Clinical Infectious Diseases 1994:18(Suppl 1):S57-60

Data Presented at the Dublin International Meeting on CFS 18-20 May 1994 (under the auspices of the World Federation of Neurology). Prof. Dr Rainer.


Immunology. R Patarca. Journal of CFS 1995:1:3-4:195-202


Neuroimmune mechanisms in health and disease: 2. Disease. H Anisman, MG Baines et al. Can Med Assoc J. 1996:155(8):1075-1082

Autoantibodies to Nuclear Envelope Antigens in Chronic Fatigue Syndrome. K Konstantinov, A von Mikecz et al. J. Clin. Invest. 1996:98:8:1888-1896


Biochemical Evidence for a Novel Low Molecular Weight 2-5A-Dependent RNase L in Chronic Fatigue Syndrome. RJ Suhadolink, DL Peterson et al. Journal of Interferon and Cytokine Research 1997:17:377-385

Elevation of Bioactive Transforming Growth Factor-9 in Serum from Patients with Chronic Fatigue Syndrome. AL Bennett, CC Chao et al. Joumal of Clinical Immunology 1997:17:2:160-166

Elevated apoptotic cell population in patients with chronic fatigue syndrome: the pivotal role of protein kinase RNA. A Vojdani, Mghoneum et al. Joumal of Internal Medicine 1997:242:465-478


Immunologic Status Correlates with Severity of Physical Symptoms in Chronic Fatigue Syndrome Patients. S Wagner, L Heider et al. Proceedings of Fourth International AA CFS Research & Clinical Conference on CFIDS 1998.

CD4 Lymphocytes from Patients with Chronic Fatigue Syndrome Have Decreased Interferon-gamma Production and Increased Sensitivity to Dexamethasone. Jvisser, B Blauw et al. Journal of Infectious Diseases 1998:177:451-4

Biochemical Dysregulation of the 2-5A/RNase L Antiviral Defense Pathway in Chronic Fatigue Syndrome. 4h International AACFS Conference 1998.

T-Lymhocytes in CFS: In Vitro Reaction to Mutagens. 4th International AACFS Research & Clinical Conference on CFIDS 1998.

Lymph Node Morphology and Phenotype in Chronic Fatigue Syndrome. 4h International AACFS Research & Clinical Conference on CFIDS 1998.

Fatigue Syndromes and the Aetiology of Autoimmune Disease. A Poteliakhoff. Journal of Chronic Fatigue Syndrome 1998:4(4):31-49

Coincidental Splenectomy in Chronic Fatigue Syndrome. BJ Miller, JL Whiting, AD Clouston. Journal of Chronic Fatigue Syndrome 1998:4(l):37-42

A Study of the Immunology of the Chronic Fatigue Syndrome: Correlation of Immunologic Parameters to Health Dysfunction. IS Hassan, BA Bannister et al. Clinical Immunology and Immunopathology 1998:87:1:60-67


Chronic Immundysfunction. Prof. Dr Rainer.